Summarized by Masters of Longevity from PR Newswire.
A press release about a medical technology company inaugurating a new on-site Innovation Laboratory to boost assay development and translational biomarker research, inviting readers to learn how the facility will support future product and scientific initiatives.
Key Takeaways
- CND opened an Innovation Laboratory in Scottsdale to support assay development and translational biomarker research.
- The new facility is separate from the company’s CLIA-certified and CAP-accredited clinical laboratory operations.
- CND’s Syn-One test has been used by over 3,500 clinicians in more than 70,000 patient evaluations.
